BfArM - Federal Institute for Drugs and Medical Devices

Navigation and service

  1. Homepage
  2. Medicinal products
  3. Pharmacovigilance
  4. Risk information

Dear Doctor Letter (Rote-Hand-Brief) on Spinraza (nusinersen): communicating hydrocephalus not related to meningitis or bleeding reported

2018.07.31

Active substance: nusinersen

The marketing authorization holder, Biogen, informs of the occurrence of communicating hydrocephalus not related to meningitis or bleeding under treatment with Spinraza. Biogen informs on several measures that should be followed.

Download DHPC / Information letter , Download_VeroeffentlichtAm_EN PDF, 306KB, File is accessible